ConductScience.org, home

Library / Trial comparisons

Patients Receiving cCTA and FFRCT >0.80 vs Patients Receiving cCTA and FFRCT≤0.80: serious adverse events

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.002530.001450.00442wilsonClinicalTrials.gov
Risk in group 20.009080.006750.0122wilsonClinicalTrials.gov
Risk difference, group 1 minus group 2-0.00654-0.00985-0.00354newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 20.2790.1470.529logClinicalTrials.gov
Odds ratio, group 1 over group 20.2770.1460.526logClinicalTrials.gov
Number needed to treat, for one fewer participant with a serious adverse event on Patients Receiving cCTA and FFRCT >0.80 than on Patients Receiving cCTA and FFRCT≤0.80153101282from the risk difference intervalClinicalTrials.gov

Groups 2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1Patients Receiving cCTA and FFRCT >0.80All clinically stable, symptomatic patients diagnosed with CAD by coronary computed tomography angiography (cCTA) and received FFRCT analysis results.124,737EG000ClinicalTrials.gov
Group 2Patients Receiving cCTA and FFRCT≤0.80All clinically stable, symptomatic patients diagnosed with CAD by coronary computed tomography angiography (cCTA) and received FFRCT analysis results.434,737EG001ClinicalTrials.gov

Harm 2

FieldValueSource
What it countsTotal, serious adverse eventsClinicalTrials.gov
Time frameClinical Events at 1 yearClinicalTrials.gov

Trial 8

FieldValueSource
TitleAssessing Diagnostic Value of Non-invasive FFRCT in Coronary CareClinicalTrials.gov
NCT numberNCT02499679ClinicalTrials.gov
PhasesClinicalTrials.gov
ConditionsCoronary Artery DiseaseClinicalTrials.gov
InterventionsClinicalTrials.gov
Lead sponsorHeartFlow, Inc.ClinicalTrials.gov
Results first posted2025-07-30ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT02499679?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.